iHuman annual r&d spending
2020
2021
2022
2023
2024
2025
iHuman R&D Spending Growth & History (IH)
iHuman's r&d spending was $29.8M for fiscal 2025.
View full iHuman company overviewiHuman annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $29.8M | −$4.1M | −12.19% |
| 2024 | 2024-12-31 | $33.9M | −$2.3M | −6.43% |
| 2023 | 2023-12-31 | $36.3M | −$9.2M | −20.19% |
| 2022 | 2022-12-31 | $45.5M | −$19.7M | −30.26% |
| 2021 | 2021-12-31 | $65.2M | $34.6M | +113.16% |
| 2020 | 2020-12-31 | $30.6M | — | — |
iHuman r&d spending trends
Over the last five fiscal years, iHuman's r&d spending decreased from $30.6M to $29.8M, a change of −$769,000.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review iHuman source filings ↗